138 related articles for article (PubMed ID: 9058767)
21. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
22. Active immunization with complementary peptide PBM 9-1: preliminary evidence that it modulates experimental allergic encephalomyelitis in PL/J mice and Lewis rats.
Zhou SR; Whitaker JN
J Neurosci Res; 1996 Aug; 45(4):439-46. PubMed ID: 8872904
[TBL] [Abstract][Full Text] [Related]
23. Overcoming unresponsiveness in experimental autoimmune encephalomyelitis (EAE) resistant mouse strains by adoptive transfer and antigenic challenge.
Shaw MK; Zhao XQ; Tse HY
J Vis Exp; 2012 Apr; (62):e3778. PubMed ID: 22507967
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
[TBL] [Abstract][Full Text] [Related]
25. Prior exposure to superantigen can inhibit or exacerbate autoimmune encephalomyelitis: T-cell repertoire engaged by the autoantigen determines clinical outcome.
Das MR; Cohen A; Zamvil SS; Offner H; Kuchroo VK
J Neuroimmunol; 1996 Dec; 71(1-2):3-10. PubMed ID: 8982096
[TBL] [Abstract][Full Text] [Related]
26. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
Bouwer HG; Hinrichs DJ
J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
[TBL] [Abstract][Full Text] [Related]
27. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.
Kono DH; Urban JL; Horvath SJ; Ando DG; Saavedra RA; Hood L
J Exp Med; 1988 Jul; 168(1):213-27. PubMed ID: 2456367
[TBL] [Abstract][Full Text] [Related]
28. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody.
Mannie MD; Morrison-Plummer J; McConnell TJ
J Immunol; 1993 Dec; 151(12):7293-306. PubMed ID: 7505025
[TBL] [Abstract][Full Text] [Related]
30. Mice resistant to experimental autoimmune encephalomyelitis have increased thymic expression of myelin basic protein and increased MBP specific T cell tolerance.
Liu H; MacKenzie-Graham AJ; Kim S; Voskuhl RR
J Neuroimmunol; 2001 Apr; 115(1-2):118-26. PubMed ID: 11282161
[TBL] [Abstract][Full Text] [Related]
31. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
[TBL] [Abstract][Full Text] [Related]
32. Relative susceptibility of SJL/J and B10.S mice to experimental allergic encephalomyelitis is correlated with high and low responsiveness to myelin basic protein.
Binder TA; Clark RB; Goldschneider I
J Neuroimmunol; 1991 Dec; 35(1-3):31-43. PubMed ID: 1720137
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice.
Chen Y; Hancock WW; Marks R; Gonnella P; Weiner HL
J Neuroimmunol; 1998 Mar; 82(2):149-59. PubMed ID: 9585811
[TBL] [Abstract][Full Text] [Related]
34. The thymus plays a role in oral tolerance induction in experimental autoimmune encephalomyelitis.
Song F; Gienapp IE; Shawler T; Guan Z; Whitacre CC
Ann N Y Acad Sci; 2004 Dec; 1029():402-4. PubMed ID: 15681792
[TBL] [Abstract][Full Text] [Related]
35. LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells.
Duplan V; Beriou G; Heslan JM; Bruand C; Dutartre P; Mars LT; Liblau RS; Cuturi MC; Saoudi A
J Immunol; 2006 Jan; 176(2):839-47. PubMed ID: 16393967
[TBL] [Abstract][Full Text] [Related]
36. Role of CD8+ T cells in murine experimental allergic encephalomyelitis.
Jiang H; Zhang SI; Pernis B
Science; 1992 May; 256(5060):1213-5. PubMed ID: 1375398
[TBL] [Abstract][Full Text] [Related]
37. T-helper lymphocytes specific for myelin basic protein: activation-induced refractoriness of IL-2 production pathways augments an anti-CD4-mediated proliferative deficit.
Mannie MD; Truman H; Morrison-Plummer J
Cell Immunol; 1994 Apr; 154(1):484-97. PubMed ID: 7510586
[TBL] [Abstract][Full Text] [Related]
38. Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen.
Rott O; Wekerle H; Fleischer B
Int Immunol; 1992 Mar; 4(3):347-53. PubMed ID: 1567791
[TBL] [Abstract][Full Text] [Related]
39. Active and passive experimental autoimmune encephalomyelitis in strain 129/J (H-2b) mice.
Fritz RB; Zhao ML
J Neurosci Res; 1996 Aug; 45(4):471-4. PubMed ID: 8872908
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties.
Beraud E; Balzano C; Zamora AJ; Varriale S; Bernard D; Ben-Nun A
J Neuroimmunol; 1993 Aug; 47(1):41-53. PubMed ID: 7690770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
